CanadaVenlafaxine XR 75 mg extended‑release capsules (VENLAFAXINE XR, DIN 02339250, lot 2505003230) distributed by Pro‑Doc Lté are affected. The batch was recalled because dissolution is out of specification. Verify if your product is the affected lot, consult your healthcare provider before stopping the medicine or for health concerns, contact Pro‑Doc Lté with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: Pro-Doc Lté., 2925 boul. Industriel,, Laval, Qc,, H7L 3W9.
How to identify it
Brand: VENLAFAXINE XR; Product Name: VENLAFAXINE XR; Market Authorization: DIN 02339250; Dosage Form: Capsule (extended release); Strength: Venlafaxine (Venlafaxine Hydrochloride) 75mg; Lot: 2505003230
The hazard
Dissolution is out of specification in the affected batch.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)